Trial intelligence / Profile preview

Treximet vs BCM for Acute Migraine

NCT00573170Phase 3Completed

Sponsor
GSK
Start
Feb 2008
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sumatriptan in migraine, sponsored by GSK. Started Feb 2008; status: completed.

02

Drugs

sumatriptan
03

Conditions

migraine

Beyond the preview

Go deeper on NCT00573170.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00573170.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call